• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
YIN Ling,ZHANG Xiuzhen,CHEN Wenwen,LIU Yanlin,GENG Tao,DANG Heqin.Analysis of narcotic use in inpatients pharmacy of our hospital in 2016[J].Journal Of Pharmaceutical Research,2018,37(4):237-239[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3495times   Download 3261次 QR Code for this article
Scan with your phone!
2016年我院住院药房麻醉药品使用情况分析
尹玲,张秀珍,陈文文,刘燕琳,耿涛,党和勤
Font:Larger+|Default|Smaller-
(泰山医学院附属医院药剂科,山东 泰安 271000)
摘要:
目的 为医疗机构麻醉药品的科学管理和临床合理用药提供参考。方法 从HIS系统中调取2016年我院住院患者麻醉药品使用数据,对其消耗量、销售金额、DDDs、B/A、DDC和各科室使用量等进行统计分析。结果 硫酸吗啡缓释片、磷酸可待因片和盐酸羟考酮缓释片(10 mg)的消耗量稳居前3位。注射用盐酸瑞芬太尼、枸橼酸舒芬太尼和盐酸羟考酮缓释片(10 mg)的销售金额居前3位。注射用盐酸瑞芬太尼、枸橼酸舒芬太尼和盐酸吗啡注射液的DDDs居前3位。注射用盐酸瑞芬太尼、枸橼酸舒芬太尼和盐酸布桂嗪注射液的B/A值均等于1,同步性较好,其它药品均有偏差。枸橼酸舒芬太尼注射液的DDC值最高,磷酸可待因片的最低。我院有56%的科室使用了麻醉药品,但主要集中在肿瘤科,其使用量占我院总消耗量的67.49%。结论 我院麻醉药品品规齐全,能够满足临床需求,应用基本合理。
关键词:  麻醉药品  限定日剂量  应用分析
DOI:10.13506/j.cnki.jpr.2018.04.014
基金项目:
Analysis of narcotic use in inpatients pharmacy of our hospital in 2016
YIN Ling,ZHANG Xiuzhen,CHEN Wenwen,LIU Yanlin,GENG Tao,DANG Heqin
(Department of Pharmacy,Affiliated Hospital of Taishan Medical University,Taian 271000,China)
Abstract:
Objective To provide reference for the scientific management and the rational usage of narcotic drugs.Methods The utilization of narcotic drugs for inpatients in our hospital in 2016 were collected from HIS,and analyzed statistically in respects of consumption amount,consumption sum,DDDs,B/A,DDC and consumption amount of the different departments.Results The consumption amount of Morphine Sulfate Sustained-release Tablets,Codeine Phosphate Tablets and Oxycodone Hydrochloride Prolonged-release Tablets (10 mg) ranked the first 3 places.The consumption sum of Remifentanil Hydrochloride for Injection,Sufentanil Citrate Injection and Oxycodone Hydrochloride Prolonged-release Tablets (10 mg) ranked the first 3 places.Remifentanil Hydrochloride for Injection,Sufentanil Citrate Injection and Morphine Hydrochloride Injection Bucinnazine Hydrochloride Injection steadily occupied the first 3 places in the list of DDDs.B/A value of Remifentanil Hydrochloride for Injection,Sufentanil Citrate Injection and Bucinnazine Hydrochloride  Injection were all equal to 1 and synchronized well,others all had deviation.The DDC of Sufentanil Citrate Injection took up the first place,and Codeine Phosphate Tablets took up the last 1 place.There were 56% departments used narcotic drugs in our hospital,but mainly in the department of oncology and general surgery, accounting for 56%.Conclusion The variety and dosage form of narcotic drugs could meet the clinical needs and its application was basically reasonable.
Key words:  Narcotic drugs  Define daily dose  Utilization analysis
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.